MIRA INFORM REPORT

 

 

Report Date :

04.02.2008

 

IDENTIFICATION DETAILS

 

Name :

CASSEL RESEARCH LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

PK – 19, Phase – V, Industrial Estate, Ekkatuthangal, Chennai – 600097, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

21.12.1998

 

 

Com. Reg. No.:

18-41617

 

 

CIN No.:

[Company Identification No.]

U24231TN1998PTC041617

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEC04118C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals and Drugs

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 34000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

PK – 19, Phase – V, Industrial Estate, Ekkatuthangal, Chennai – 600097, Tamilnadu, India

Tel. No.:

91-44-22253280 / 2326679 / 22253618

Fax No.:

91-44-2311628 / 22251628

E-Mail :

cassel@casselorg.com / casselchennai@yahoo.com

Website :

http://www.casselorg.com

 

 

Factory :

Unit – II, Plot No. 54, SIDCO Industrial Estate, Ekkaduthangal, Chennai – 600097, Tamilnadu, India

Tel No. :

91-44-22253280

 

 

DIRECTORS

 

Name :

Mr. Rajamani Murugan

Designation :

Managing Director

Address :

F – 16, High Quarters, Pillarsallas, Chennai – 600075, Tamilnadu, India

Date of Birth/Age :

19.02.1970

Date of Appointment :

21.12.1998

 

 

Name :

Mr. R. Nehrudassan

Designation :

Director

Address :

No. 42/1881, Vandikkar Street, Thanjavur, Tamilnadu, India

 

 

Name :

Mr. R. Lakshmanan

Designation :

Director

Address :

No. 42/1881, Vandikkar Street, Thanjavur, Tamilnadu, India

 

 

Name :

Mr. K. Anbuselvan

Designation :

Director

Address :

No. 56/1462, South Rampart, Thanjavur, Tamilnadu, India

 

 

Name :

Mr. M Venkatesan

Designation :

Director

Address :

No. 7, 1st Cross Street, Ammaiya Pillai, Vayaiur Road, Trichy, Tamilnadu, India

 

 

Name :

Mr. K. Ravichandran

Designation :

Director

Address :

No. 42/1881, Vandikkar Street, Thanjavur, Tamilnadu, India

 

 

KEY EXECUTIVE

 

Name :

Mr. S. Viswanathan

Designation :

Company Secretary

 

 

Name :

Mr. R. Sucharitbra

Designation :

Company Secretary

Address :

28/59, Vivekananda Street, Gandhi Nagar, Saligraman, Chennai – 600096, Tamilnadu, India

Qualification :

B. Com. A.C.S.

Tel No.:

91-44-23623179

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Mr. M Venkatesan

 

10000

Mr. K. Anbuselvan

 

10000

Mr. R. Lakshmanan

 

10000

Mr. K. Ravichandran

 

20000

 

 

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals and Drugs

 

 

Product :

  • Drugs
  • Pharmaceuticals

 

 

GENERAL INFORMATION

 

Suppliers :

  • Aarti Drugs Limited
  • Ajit Foils and Allied
  • Aarti Healthcare Limited
  • Balaji Associates
  • Bhikshu Chemicals
  • Bulwark Pharmaceuticals
  • Cadia Healthcare Limited
  • Glenmark Pharmaceuticals Limited
  • Indian Aluminium Company
  • J P Pharma Chem Industries
  • Juharmal and Company
  • Kores [India] Limited
  • Likir Chemicals Limited
  • Om Impex
  • Parle Pharma Machineries
  • Radiant Rubbers
  • Rooth Trade Link Private Limited
  • Stanpack Pharma Private Limited
  • Textile Dye-Chem Private Limited
  • Ultra Impressions Vora Corporation
  • Wincoar Colour and Coating
  • Tamuna Roto Prints

 

 

Customers :

  • Aretaus Pharmaceuticals Private Limited
  • Bharath Biological
  • Cadila Health Care Limited
  • Enma Pharmaceuticals
  • Galpha Laboratories Limited
  • German Remedies Limited
  • Hextar Pharmaceuticals Limited
  • Inbriss Labs Private Limited
  • Lessac Research Laboratories
  • May India Laboratories Private Limited
  • MMC Health Care Limited
  • Nile India Formulations
  • Orbit Health Care
  • Reign [India] Formulations Private Limited
  • Suzen Pharmaceuticals Private Limited
  • Tychos Therapeutics
  • Wipra Pharmaceuticals
  • Zedawn Formulation Private Limited

 

 

Bankers :

  • Indian Overseas Bank, Adyar Branch, Chennai – 600020, Tamilnadu, India
  • City Union Bank Limited, 706, Mount Road Branch, Chennai – 600006, Tamilnadu, India
  • ABN Amro Bank
  • ICICI Bank
  • HDFC Bank

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

V N Associates

Chartered Accountants

Address :

No. 8 Kennady First Street, Luz, Mylapore, Chennai – 600004, Tamilnadu

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

750000

Equity Shares

Rs.10/- each

Rs.7.500 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

630000

Equity Shares

Rs.10/- each

Rs.6.300 millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

6.300

6.300

6.300

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

2.246

2.207

1.008

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

8.546

8.507

7.308

LOAN FUNDS

 

 

 

1] Secured Loans

54.233

45.300

57.324

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

54.233

45.300

57.324

DEFERRED TAX LIABILITIES

0.146

0.000

0.765

 

 

 

 

TOTAL

62.925

53.807

65.397

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

64.777

66.614

71.667

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

42.528

18.300

10.367

 

Sundry Debtors

37.721

36.666

18.964

 

Cash & Bank Balances

0.415

0.086

0.042

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

10.812

5.224

1.680

Total Current Assets

91.476

60.276

31.053

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

90.076

68.122

34.324

 

Provisions

3.449

5.153

3.051

Total Current Liabilities

93.525

73.275

37.375

Net Current Assets

[2.049]

(12.999)

(6.322)

 

 

 

 

MISCELLANEOUS EXPENSES

0.197

0.192

0.052

 

 

 

 

TOTAL

62.925

53.807

65.397

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2006

31.03.2005

Sales Turnover

 

109.606

105.110

Other Income

 

15.964

0.096

Total Income

 

125.570

105.206

 

 

 

 

Profit/(Loss) Before Tax

 

0.958

(0.932)

Provision for Taxation

 

0.524

0.807

Profit/(Loss) After Tax

 

0.434

(1.739)

 

 

 

 

Expenditures :

 

 

 

 

Consumption of stores and spares parts

 

0.000

82.939

 

Employee Cost and Direct Expenditure

 

0.000

3.944

 

Depreciation & Amortization

 

9.776

4.189

 

Administrative and Other Expenses

 

114.836

15.066

Total Expenditure

 

124.612

106.138

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

NA

0.35

(1.65)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

0.87

(0.89)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

0.75

(0.91)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.11

(0.13)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

17.29

13.94

12.96

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.98

0.82

0.83

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Bankers Charges Report as per Registry

 

 

Name of the company

CASSEL RESEARCH LABORATORIES PRIVATE LIMITED

Presented By

Indian Overseas Bank, Adyar Branch, Chennai – 600020

1) Date and description of instrument creating the change

19.06.2004

a) Term Loan and cash credit demand promissory note.

b) Form F 16 (EH)

c) Letter of hypothecation (in case of open advance only

d) Hypothecation of book debts

e) Term loan agreement

f) Letter of hypothecation (in case of machinery only)

g) Letter of hypothecation (for securing machineries / vehicles / goods / book debts)

2) Amount secured by the charge/amount owing on the securities of charge

Rs.40.800 millions

Nature of  facilities :

Term Loan Rs.33.300 millions

Cash Credit Rs.7.500 millions

Total                    40.800 millions

 

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Security: hypothecation of all stocks in trade, book debts in trade, and machineries in trade, present and future of the company. In first charge of Indian Overseas Bank, Adyar Branch, Chennai – 600020

4) Gist of the terms and conditions and extent and operation of the charge.

Term Loan Int. @ BPLR + 3% i.e. 14.00% p.a. with monthly rests. Margin @ 25% for machinery and 50

5 for land and building.

 

Cash Credit Int. @ BPLR + 3% i.e., 14.00%p.a. with monthly rests. Margin @ 25% for stocks and 40% for book debts.

 

Tem Loan purpose: Purchase of machineries and construction of building at Plot No. 54, TNSIDCO Industrial Estate, Thirumudivakkam, Sriperumbudur Taluk. Cash credit purpose: Stocks and Book Debts.

5) Name and Address and description of the person entitled to the charge.

Indian Overseas Bank

Adyar Branch, Chennai – 600020

6) Date  and brief description of instrument modifying the charge

Letter of Confirmation dated 21.06.2004 for EM by deposit of Title Deeds Dated 19.06.2004

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

EM by Deposit of Title Deeds

 

EM of Company Property [Land and Building] at Thirumudivakkam Village, Sriperumbudur Taluk, Chengalpur District, Survey No. 129, 130, Extent : 2 Acres and 50 Cents. North By : Cannal, South Bu : Canal. East by : Land belong to Pasule Wajid. West By : Land Belong to SIDCO

 

Survey No.

Extent

129

A1.80 cents

130

A0.25 Cents

Total Extent

A2.05 Cents

 

Land A2.05 Cents and Building, Property in the name of Cassel Research Laboratories Private Limited

SRO : Padappai, Doc No. 235/2004 as commissions, Charges etc. in first charge of IOB, Adyar Branch, Chennai – 600 020

 

 

Corporate identity number (CIN) Foreign company registration number

U24231TN1998PTC041617

Name of the Company

CASSEL RESEARCH LABORATORIES PRIVATE LIMITED

Address

P.K. 19, Phase – V, Industrial Estate, Ekkaduthangal, Chennai – 600017, Tamilnadu

This form is for

Modification of Charges

Type of Charge

Immovable Property, Any Interest in Immovable property, Book Debts and Others

Particulars of the charge holder 

Indian Overseas Bank

Adyar Branch, Chennai – 600020, Tamilnadu

E – Mail : adyarbr@chemrc01.ionet.co.in

Amount secured by the charge

Rs.73.529 millions

Brief of the principal terms and conditions 

Rate of Interest: Cash Credit against stock and book debts – Loan amount of Rs.22.000 millions. Interest at 13.25%

 

Margin: Cash Credit Loan – Margin at 25% against stock and 50% against book debts

 

Extent and operation of the charge : First charge over all stocks in trade, book debts and machineries, present and future of the company

 

Others: Modification of charge is due to enhancement in term loan from Rs.33.300 millions to RS.44.000 millions and reduction in letter of credit from Rs.10.000 millions to Rs.6.600 millions and the over all limit o fRs.73.529 millions

Description of the property charged indicating

Letter of Hypothecation created by the Indian Overseas Bank, Adyar Branch, Chennai – 20 by dated 7th June, 2007

Date of Instrument creating or modifying the charge

07.06.2007

Particular of the present modification 

Additional Term Loan of Rs.10.700 millions and reduction in letter of credit by Rs.3.400 millions and the over all limit of Rs.73.529 millions

Present Loan : Term Loan Rs.44.000 millions, cash credit Rs.22.000 millions, Letter of credit : Rs.6.600 millions and letter of Guarantee of Rs.0.929 million

 

Fixed Assets

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.36

UK Pound

1

Rs.78.29

Euro

1

Rs.58.48

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions